{"title": "The definition and risks of Cytokine Release Syndrome-Like in 11 COVID-19-Infected Pneumonia critically ill patients: Disease Characteristics and Retrospective Analysis", "doi": "10.1101/2020.02.26.20026989", "citation_id": "2020.02.26.20026989v1", "date": "2020-02-27", "laguage": "en", "journal_title": "medRxiv", "first_page": "2020.02.26.20026989", "abstract": "<p>IMPORTANCE: COVID-19-infected pneumonia patients with severe immune abnormalities and risk of cytokine release syndrome. The definition, prevention, and treatment of COVID-19-infected pneumonia in critically ill patients with cytokine release syndrome symptoms is an important problem.</p>", "twitter_description": "IMPORTANCE: COVID-19-infected pneumonia patients with severe immune abnormalities and risk of cytokine release syndrome. The definition, prevention, and treatment of COVID-19-infected pneumonia in critically ill patients with cytokine release syndrome symptoms is an important problem.\n\n### Competing Interest Statement\n\nThe authors have declared no competing interest.\n\n### Funding Statement\n\nno\n\n### Author Declarations\n\nAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.\n\nYes\n\nAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.\n\nYes\n\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\n\nYes\n\nI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.\n\nYes\n\na.) Basic information of the patient: name, gender, age, hospitalization number, diagnosis, date of admission, condition, laboratory examination results, chest CT scan, nursing care, and treatments (i.e. antiviral treatment, corticosteroid treatment, and respiratory support. The records were taken by a team of trained doctors, and the data were obtained from electronic medical records. b. Data generated by bedside monitor: heart rate, respiration, invasive / non-invasive blood pressure, blood oxygen saturation, hemodynamic monitoring. c. Medical order execution information: administration times for all medicines, drug name, dose, concentration, route, automatically generated in and out quantity. These data were automatically collected by the ICU clinical information system.", "full_text_html_url": "https://www.medrxiv.org/content/10.1101/2020.02.26.20026989v1.full", "public_url": "https://www.medrxiv.org/content/10.1101/2020.02.26.20026989v1", "abstract_html_url": "https://www.medrxiv.org/content/10.1101/2020.02.26.20026989v1.abstract", "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/02/27/2020.02.26.20026989.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.", "publisher": "Cold Spring Harbor Laboratory Press", "pisa": "medrxiv;2020.02.26.20026989v1", "access_rights": "restricted", "authors": ["Wenjun Wang", "Jianxing He", "puyi Lie", "liyan Huang", "Sipei Wu", "yongping lin", "xiaoqing liu"]}